"Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (⬇️vascular events ) greater, the longer you treat: 1y: RRR 12% 3y: 20% 5y: 23% 7y: 29% lifetime (estimated by genetics): 55% https://t.co/uvBhHEM9JC https://t.co/2VfjaFeevD
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2022 – Nov 2024Where it's discussed
-
X / Twitter123 posts
-
YouTube5 videos
-
Facebook2 posts
AI synopsis
What people are saying
Several discussions highlight significant aspects of the research, such as the statement, 'The benefits of LDL-C lowering do not seem to be fixed but increase steadily with longer durations of treatment.' Many posters emphasize the need for early intervention and continuous treatment, using phrases like 'start primary prevention much earlier' and 'excellent evidence showing earlier = better,' which reflect both urgency and trust in the results.
Many discussions reflect a shared understanding of the publication's findings, with users expressing support for the long-term benefits of cholesterol-lowering therapy.
There is a high level of curiosity regarding how these findings can be implemented in practice, indicated by numerous users asking clarifying questions and sharing insights.
Though the discussions show a moderate level of engagement involving technical terms and references to the publication, they lean towards brief reactions rather than in-depth analysis.
The perceived significance of the publication for improving cardiovascular health is strong, with many considering it essential for informing future treatment approaches.
Abstract in brief
- This systematic review and meta-analysis examined how long-term use of cholesterol-lowering drugs affects major cardiovascular events, using data from 21 trials involving over 184,000 patients.
- Findings indicated a direct relationship between treatment duration and the reduction of risk for major vascular events, with benefits increasing the longer patients were treated.
- Each mmol/L decrease in low-density lipoprotein cholesterol (LDL-C) led to a significant risk reduction over time, emphasizing that these benefits are cumulative rather than fixed.
Top posts
Most liked on X and BlueskyCompounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/abN9fxQ4d0
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/SsyYq9jmxa @Drlipid @lipiddoc @nationallipid @ASPCardio @society_eas @ESC_Journals @ProfKausikRay @SABOURETCardio @maciejbanach
LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary prevention th much earlier and in all with higher than optimal LDL-c/apoB levels ! @MedTwitter @Cardiotwitter https://t.co/QFnJkcbRIW
This analysis highlights the compounding and longitudinal impact of #LDL-C reduction. https://t.co/Qib3cFQ6jE
"The benefits of LDL-C lowering do not seem to be fixed but increase steadily with longer durations of treatment." LDL-C skeptics/deniers beware. https://t.co/iCykQFZ8Xh
All mentions
Evaluating Cholesterol Myths and Bempedoic Acid Benefits
In this video, Dr. Sten Ekberg's cholesterol claims are critically analyzed against scientific evidence. Bempedoic acid, an ATP citrate lyase inhibitor, effectively reduces LDL cholesterol with fewer side effects…
Effectiveness of Statins in Cardiovascular Risk Reduction Explained
Do statins really reduce risk of heart disease and by how much? This video explores their efficacy, safety, and the importance of timing in lipid-lowering treatment to maximize long-term cardiovascular health benefits.
Cholesterol-Lowering Therapy: Evaluating Major Cardiovascular Benefits
In this video, Dr. Susan Oliver and Cindy the dog delve into the claims made by Dr. Aseem Malhotra regarding cholesterol and statins. They reference a systematic review showing how long-term cholesterol-lowering therapy…
Exploring Veganism: Are Rocks Really Vegan?
Today we investigate claims surrounding the concept of veganism, particularly in relation to unusual alignments with spiritual beliefs. This video also highlights findings on cholesterol-lowering therapies and their…
Impact of Lipid Lowering: Triglycerides vs LDL Cholesterol on Heart Disease Risk
This study explores whether lowering triglycerides or LDL cholesterol reduces coronary heart disease risk, showing both genetic variants associated with lipid level reductions lead to similar disease risk decrease…
@DanClintonRN @radfugee @Jordan_theCoach @BioLayne @sudas1891 @mario_kratz @Paddy_Barrett Relevant papers: https://t.co/ET9h8aArT2 https://t.co/nDHNaNnMBT https://t.co/piJBRDVdxU And in your hypothetical scenario, I would estimate the diabetogenic risk (not to mention hard diabetic complications) of, say, 2.5-5 mg rosuvastatin to be even lower.
@holmanm Doesn’t this go against this well done 2022 meta analysis by Wang? https://t.co/6DhEwjUwpB
@ChrispLMarshall @Drlipid @PeterAttiaMD https://t.co/iYFIqOOfKR Help me understand
@SteveDa39872898 https://t.co/YQR7Fz7BuE cholesterol lowering medications. https://t.co/JN9q8LiCOx
@cambridge_pt It's the ApoB that is inside the LDL that is the problem. Even taking statins sems to lower heart disease risk by lowering High LDL. https://t.co/Au3b5TUXIS https://t.co/FiwxE2SiLP
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @amitvkhera: Additional evidence in @CircOutcomes (h/t @MarilynMann) That when it comes to LDL (‘bad’) cholesterol reduction Duration…
@sean_bernstein both RRR and ARR increase with time. this is all published https://t.co/yRyXnDVm88
RT @pnatarajanmd: LDL-C reduction and CVD risk is not proportional over time. (↓LDL-C via genetics yields ↑↑ CVD effects vs ↓LDL-C via medi…
RT @TheLipidGuy: "The benefits of LDL-C lowering do not seem to be fixed but increase steadily with longer durations of treatment." LDL-C…
RT @pabeda1: @SABOURETCardio @kaulcsmc @GreggWStone @drpablocorral @MeralKayikcoglu Yesss!
@SABOURETCardio @kaulcsmc @GreggWStone @drpablocorral @MeralKayikcoglu Yesss!
@Gearoidmuar @MeganLeePhD @NutritionMadeS3 @FeliceJacka https://t.co/99dP0v07pW
RT @TheLipidGuy: "The benefits of LDL-C lowering do not seem to be fixed but increase steadily with longer durations of treatment." LDL-C…
RT @TheLipidGuy: "The benefits of LDL-C lowering do not seem to be fixed but increase steadily with longer durations of treatment." LDL-C…
"The benefits of LDL-C lowering do not seem to be fixed but increase steadily with longer durations of treatment." LDL-C skeptics/deniers beware. https://t.co/iCykQFZ8Xh
RT @andrebez: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis | Circulation: Cardiovascular Quality and Outcomes https://t.co/zmr2fs9cYj
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @MugaAlejandro: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis | Circulation: Cardiovascular Quality and Outcomes https://t.co/SsxivBxDgS
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/CpZ8KwjOy6
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/oVb8cy5nzA
RT @skathire: "Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (…
"Get LDL cholesterol as low as possible FOR AS LONG AS POSSIBLE" Cool new analysis: for every 39 mg/dl lowering, benefit (⬇️vascular events ) greater, the longer you treat: 1y: RRR 12% 3y: 20% 5y: 23% 7y: 29% lifetime (estimated by genetics): 55% https://t.co/uvBhHEM9JC https://t.co/2VfjaFeevD
@kevinnbass @duderfool I’m sure you’ve seen this but here’s a recent meta analysis showing compounding benefits the longer someone is treated with statins. Excellent evidence showing earlier = better. Would be perfect for your analyses https://t.co/8QNxn9s5es
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
RT @ethanjweiss: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review a…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/abN9fxQ4d0
RT @BrezanSimonMD: LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary preventio…
@NutritionMadeS3 @drscottyk
LDL cholesterol LOWERING : THE LONGER THE BETTER. Some of us saying this for years- we need to start primary prevention th much earlier and in all with higher than optimal LDL-c/apoB levels ! @MedTwitter @Cardiotwitter https://t.co/QFnJkcbRIW
RT @NutritionMadeS3: landmark analysis: the longer we hold LDL-cholesterol down the stronger the benefit reduction for 1 year: 12% lower c…
RT @NutritionMadeS3: landmark analysis: the longer we hold LDL-cholesterol down the stronger the benefit reduction for 1 year: 12% lower c…
RT @NutritionMadeS3: landmark analysis: the longer we hold LDL-cholesterol down the stronger the benefit reduction for 1 year: 12% lower c…
RT @NutritionMadeS3: landmark analysis: the longer we hold LDL-cholesterol down the stronger the benefit reduction for 1 year: 12% lower c…
RT @NutritionMadeS3: landmark analysis: the longer we hold LDL-cholesterol down the stronger the benefit reduction for 1 year: 12% lower c…
RT @NutritionMadeS3: landmark analysis: the longer we hold LDL-cholesterol down the stronger the benefit reduction for 1 year: 12% lower c…
RT @NutritionMadeS3: landmark analysis: the longer we hold LDL-cholesterol down the stronger the benefit reduction for 1 year: 12% lower c…
@thalesnemo @LDLSkeptic @DrAseemMalhotra @ProfTimNoakes @ifixhearts @DrPaulMason https://t.co/q99lUufRu2
RT @pash22: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Me…
RT @pash22: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Me…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: On the back of MR studies this systematic RV & meta analysis examines the cumulative RRR of cholesterol lowering Rx. Would be interesting to know the ARR https://t.co/NOwDOvmkG5
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/ljIfTKeZcw via @Mark_Huffman et al
RT @JPSwcpmc: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
RT @JPSwcpmc: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
RT @JPSwcpmc: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
RT @agingdoc1: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
This analysis highlights the compounding and longitudinal impact of #LDL-C reduction. https://t.co/Qib3cFQ6jE
RT @JPSwcpmc: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/1vPUEwqLan
RT @JPSwcpmc: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
RT @JPSwcpmc: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/SsyYq9jmxa @Drlipid @lipiddoc @nationallipid @ASPCardio @society_eas @ESC_Journals @ProfKausikRay @SABOURETCardio @maciejbanach
RT @pnatarajanmd: LDL-C reduction and CVD risk is not proportional over time. (↓LDL-C via genetics yields ↑↑ CVD effects vs ↓LDL-C via medi…
RT @Natural_Fallacy: Benefits of LDL lowering increase steadily with longer durations of treatment. In a meta-analysis of 21 trials, every…
RT @Natural_Fallacy: Benefits of LDL lowering increase steadily with longer durations of treatment. In a meta-analysis of 21 trials, every…
RT @dranandrohatgi: Great data to d/w patients on benefits of long-term LDL lowering (slide my own): Compounding Benefits of Cholesterol-Lo…
Great data to d/w patients on benefits of long-term LDL lowering (slide my own): Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/slMJpz55HX https://t.co/4GbfWEcUi7
RT @pash22: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Me…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/NZ67BxxRN2 via @Mark_Huffman et al
RT @agingdoc1: Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and…
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/fN92wuoKZb
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis https://t.co/mahdDQRtGP